The University of Southampton
University of Southampton Institutional Repository

Supporting the lifestyle modification and treatment of type 2 diabetes for people with sever mental illness

Supporting the lifestyle modification and treatment of type 2 diabetes for people with sever mental illness
Supporting the lifestyle modification and treatment of type 2 diabetes for people with sever mental illness
This review describes the association between diabetes and the two main severe mental illnesses (SMIs), schizophrenia and bipolar illness, which have been recognised for over a century. It also explains how lifestyle modification can improve outcomes. People with SMI have an increased prevalence of other metabolic comorbidities. The increase in diabetes and metabolic syndrome is a predictor of cardiovascular disease, which is the commonest cause of death in people with SMI (accounting for up to 60% of all deaths in these people). Factors contributing to risk of disease are the same in people with SMI as in the general population, but lifestyle is probably most important because this is potentially amenable to modification. Poverty, urbanisation, poor diet and physical inactivity are key risk factors for diabetes that occur more frequently in people with SMI. SMI contributes further to diabetes risk as illustrated by studies of drug-naïve first-episode patients. Antipsychotic medications have been implicated in diabetes development. The high prevalence of diabetes has a number of clinical implications for care. First, we need to screen for diabetes, as recommended by national bodies including the National Institute for Health and Clinical Excellence (NICE) and the American Diabetes Association. Secondly, we need to implement strategies to reduce the risk of diabetes. The Salford Weight Management Clinic, established in May 2000, has shown that lifestyle modification is possible in SMI. Finally, strategies should be developed to manage the health of people with SMI who develop diabetes
diabetes, type 2 diabetes
58-63
Pendlebury, J.
2183e42b-262c-40e0-94cb-ddd3e8f91934
Holt, R.I.G.
d54202e1-fcf6-4a17-a320-9f32d7024393
Pendlebury, J.
2183e42b-262c-40e0-94cb-ddd3e8f91934
Holt, R.I.G.
d54202e1-fcf6-4a17-a320-9f32d7024393

Pendlebury, J. and Holt, R.I.G. (2008) Supporting the lifestyle modification and treatment of type 2 diabetes for people with sever mental illness. European Diabetes Nursing, 5 (2), 58-63. (doi:10.1002/edn.110).

Record type: Article

Abstract

This review describes the association between diabetes and the two main severe mental illnesses (SMIs), schizophrenia and bipolar illness, which have been recognised for over a century. It also explains how lifestyle modification can improve outcomes. People with SMI have an increased prevalence of other metabolic comorbidities. The increase in diabetes and metabolic syndrome is a predictor of cardiovascular disease, which is the commonest cause of death in people with SMI (accounting for up to 60% of all deaths in these people). Factors contributing to risk of disease are the same in people with SMI as in the general population, but lifestyle is probably most important because this is potentially amenable to modification. Poverty, urbanisation, poor diet and physical inactivity are key risk factors for diabetes that occur more frequently in people with SMI. SMI contributes further to diabetes risk as illustrated by studies of drug-naïve first-episode patients. Antipsychotic medications have been implicated in diabetes development. The high prevalence of diabetes has a number of clinical implications for care. First, we need to screen for diabetes, as recommended by national bodies including the National Institute for Health and Clinical Excellence (NICE) and the American Diabetes Association. Secondly, we need to implement strategies to reduce the risk of diabetes. The Salford Weight Management Clinic, established in May 2000, has shown that lifestyle modification is possible in SMI. Finally, strategies should be developed to manage the health of people with SMI who develop diabetes

This record has no associated files available for download.

More information

Published date: 2008
Keywords: diabetes, type 2 diabetes

Identifiers

Local EPrints ID: 70503
URI: http://eprints.soton.ac.uk/id/eprint/70503
PURE UUID: 1ade487d-4db0-4894-a3d7-04fb94add794
ORCID for R.I.G. Holt: ORCID iD orcid.org/0000-0001-8911-6744

Catalogue record

Date deposited: 12 Feb 2010
Last modified: 14 Mar 2024 02:45

Export record

Altmetrics

Contributors

Author: J. Pendlebury
Author: R.I.G. Holt ORCID iD

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×